Figure 1 from Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer
<p>MA.38 main trial results. <b>A,</b> CONSORT diagram. <b>B</b> and <b>C,</b> Results from the MA.38 trial for (<b>B</b>) PFS and (<b>C</b>) OS among patients in the CDS (blue) and SDS (red). AE, adverse event.</p>
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Drugi avtorji: | , , , , , , , , , , , , , , , , , , , |
| Izdano: |
2025
|
| Teme: | |
| Oznake: |
Označite
Brez oznak, prvi označite!
|